Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who are 18 years of age or older
- People who have been diagnosed with a specific type of high blood pressure in the lungs called Group 1 pulmonary arterial hypertension (PAH), based on recognised medical guidelines
- People who are already being monitored or treated for PAH at the study centre
- People who have had both a right heart catheterisation (a procedure to measure pressure in the heart and lungs) and a cardiac MRI scan, with both tests done within an appropriate time frame
- People for whom complete medical, imaging, and heart pressure measurement records are available and can be reviewed
- People who are willing to take part in the study and have signed a written consent form
Who may not be able to join:
- People under 18 years of age
- People whose lung blood pressure condition falls into a different category (Groups 2 through 5 pulmonary hypertension), rather than Group 1 PAH
- People who have not had both a right heart catheterisation and a cardiac MRI scan within an appropriate time frame
- People whose medical or imaging records are incomplete in a way that would prevent proper review and analysis
- People for whom follow-up medical records are not available
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aybüke Geylan, MD, Istanbul University Cerrahpasa Institute of Cardiology
Phone: +905061258579
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Risk reclassification rate after incorporation of multimodality imaging-derived RV characteristics into established non-invasive PAH risk models
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.